1. ABATACEPT TREATMENT FOR PATIENTS WITH EARLY ACTIVE PRIMARY SJOGREN'S SYNDROME: OPEN-LABEL EXTENSION PHASE OF A RANDOMIZED CONTROLLED PHASE III TRIAL

   Arends, S., Van Nimwegen, J. F., Mossel, E., Van Zuiden, G. S., Delli, K., Stel, A. J., Van der Vegt, B., Haacke, E. A., Olie, L., Los, L., Verstappen, G. M., Pringle, S. A., Spijkervet, F. K. L., Kroese, F. G. M., Vissink, A. & Bootsma, H., Jun-2020, In : Annals of the Rheumatic Diseases. 79, p. 102-102 1 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

2. Efficacy and Safety of Abatacept in Patients with Early Active Primary Sjogren's Syndrome - Open-label Extension Phase of a Randomized Controlled Phase III Trial

   van Nimwegen, J., Mossel, E., Wijnsma, R., van Zuiden, G., Delli, K., Stel, A., van der Vegt, B., Haacke, E., Olie, L., Los, L., Verstappen, G., Pringle, S., Spijkervet, F., Kroese, F., Vissink, A., Arends, S. & Bootsma, H., Oct-2019, In : Arthritis & Rheumatology. 71, 3 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

3. Clinical Phenotyping of Patients with Primary Sjogren's Syndrome Using Salivary Gland Ultrasonograhpy

   Mossel, E., van Nimwegen, J., Wijnsma, R., Stel, A., Delli, K., van Zuiden, G., Olie, L., Los, L., Vissink, A., Kroese, F., Arends, S. & Bootsma, H., Oct-2019, In : Arthritis & Rheumatology. 71, 2 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

4. Abatacept treatment for patients with early active primary Sjogren's syndrome: a single-centre, randomised, double-blind, placebo-controlled, phase 3 trial (ASAP-III study)

   van Nimwegen, J. F., Mossel, E., van Zuiden, G. S., Wijnsma, R. F., Delli, K., Stel, A. J., van der Vegt, B., Haacke, E. A., Olie, L., Los, L., Verstappen, G. M., Pringle, S. A., Spijkervet, F. K. L., Kroese, F. G. M., Vissink, A., Arends, S. & Bootsma, H., Mar-2020, In : Lancet Rheumatology. 2, 3, p. E153-E163 11 p.

   Research output: Contribution to journal › Article › Academic › peer-review

5. How do patients with systemic sclerosis experience currently provided healthcare and how should we measure its quality?

   Spierings, J., van den Ende, C. H. M., Schriemer, R. M., Moens, H. J. B., van der Bijl, E. A., Bonte-Mineur, F., de Buck, M. P. D., de Kanter, M. A. E., Knaapen-Hans, H. K. A., van Laar, J. M., Mulder, DJ., Potjewijd, J., de Pundert, L. A. J., Schoonbrood, T. H. M., Schouffoer, A. A., Stel, A. J., Vercoutere, W., Voskuyl, A. E., de Vries-Bouwstra, J. K. & Vonk, M. C., 20-Sep-2019, In : Rheumatology. kez417.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (36) »